A big risk for users in any marketplace is information asymmetry. It could often lead to losses for the users either squarely because of fraud or at times due to misunderstandings of how the marketplace works. Additionally, not understanding the underlying technology as in case of VDAs could lead to further complications.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.